The taming of Malaria
Distribution of vaccines a ‘challenge’ and costs ‘considerable’ but rollout still marks landmark moment in history

A free daily digest of the biggest news stories of the day - and the best features from our website
Thank you for signing up to TheWeek. You will receive a verification email shortly.
There was a problem. Please refresh the page and try again.
According to an oft-repeated factoid, half of all the human beings who have ever existed on Earth have been killed by malaria – equivalent to around 54.5 billion people.
Some sceptics have questioned whether the mosquito-borne illness really has claimed that many lives. BBC journalist Tim Harford investigated the issue on his podcast More or Less in 2013, interviewing Brian Faragher, emeritus professor of medical statistics at Liverpool School of Tropical Medicine.
Faragher told Harford that “it’s difficult to find evidence to support that claim”. Instead, analysis of historic data suggested the true total percentage of people who have died from malaria “is probably somewhere between” 4% and 5%, he suggested.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
That still equates to a huge number of lives, but the good news is that numbers of both malaria infections and deaths have been falling in recent decades.
In 2000, nearly 900,000 people died of malaria, mostly in poorer regions of the world, such as sub-Saharan Africa. But since then, insecticide-treated bed nets, antimalarial medications and the spraying of homes with insecticides has significantly reduced the problem. In Africa alone, these interventions are estimated to have prevented 663 million malaria cases between the start of the century and 2015.
And since then, a “new hope in the fight against malaria arrived”, said Vox, “via the world’s first-ever malaria vaccine”, which will be rolled across 12 African countries over the next two years.
An initial 18 million doses of the vaccine have been earmarked for the countries where the risk of malaria to children is the greatest, according to a statement from the global vaccine alliance Gavi, the World Health Organization (WHO) and Unicef.
“This vaccine has the potential to be very impactful in the fight against malaria, and when broadly deployed alongside other interventions, it can prevent tens of thousands of deaths every year,” said Thabani Maphosa, managing director of country programmes delivery at Gavi.
Another 16 African countries have asked for access to the vaccine and “will be hoping for supplies when production has been scaled up”, The Guardian said.
Over the past four years, the vaccine, known as RTS,S/AS01, has been given to more than 1.7 million children in Ghana, Kenya and Malawi. The result has been “both a substantial reduction in severe malaria and a fall in child deaths”, Gavi said.
The vaccine “is being heralded as a game changer”, said The Irish Times, delivering immediate hope to a continent where almost half a million children under the age of five die of malaria each year.
Another vaccine, known as R21/Matrix-M, developed at Oxford University, is also awaiting WHO pre-qualification.
The next challenge with both vaccines will be distribution. More than 400 million children live in Africa, “and this number is expected to grow”, said Vox. The RTS,S vaccine is a four-dose regime, while R21 involves three doses. So even if only 200 million children are deemed eligible, up to 800 million doses will be needed.
The costs will also be considerable. At an estimated $8 per dose (£6), the vaccination campaign is forecast to cost between $4.8 and $6.4 billion (£3.7bn and £5bn). Even at the lower end of this calculation, this would be “higher than the GDP of over a dozen African countries”, Vox noted.
But despite such barriers, the planned rollout marks a landmark moment in history.
Currently, “nearly every minute, a child under five years old dies of malaria”, said Unicef associate director of immunisation Ephrem T. Lemango. “For a long time, these deaths have been preventable and treatable – but the rollout of this vaccine will give children, especially in Africa, an even better chance at surviving.”
This article first appeared in The Week’s Global Digest newsletter. Sign up for a preview of the international news agenda, sent to your inbox every Monday.
Continue reading for free
We hope you're enjoying The Week's refreshingly open-minded journalism.
Subscribed to The Week? Register your account with the same email as your subscription.
Sign up to our 10 Things You Need to Know Today newsletter
A free daily digest of the biggest news stories of the day - and the best features from our website
Arion McNicoll is a freelance writer at The Week Digital and was previously the UK website’s editor. He has also held senior editorial roles at CNN, The Times and The Sunday Times. Along with his writing work, he co-hosts “Today in History with The Retrospectors”, Rethink Audio’s flagship daily podcast, and is a regular panellist (and occasional stand-in host) on “The Week Unwrapped”. He is also a judge for The Publisher Podcast Awards.
-
New Covid variant BA.2.86: does the UK booster programme go far enough?
Talking Point Some MPs and experts say criteria for jabs is ‘too narrow’ ahead of ‘rocky ride’ this winter
By Chas Newkey-Burden Published
-
Covid testing to be ramped up for winter
Speed Read Scientists fear UK could be ‘flying blind’ on infection rates due to lack of monitoring programmes
By Harriet Marsden Published
-
Why measles is threatening children right across the UK
feature The UK lost its measles-free status in 2019, indicating that the measles virus was circulating and there was inadequate vaccination to prevent its spread
By The Week Staff Published
-
Lyme disease: vaccine could halt rise of tick-borne disease
feature Experts have issued a warning as cases rise in the UK
By Chas Newkey-Burden Published
-
Sanofi: the new protein-based Covid vaccine to be used in the UK
feature Protein-based vaccines have been safely used for years against hep B, flu and shingles
By The Week Staff Published
-
mRNA technology and a vaccine for cancer
feature Cure is ‘in our grasp’ say the scientists behind the BioNTech Covid-19 jab
By The Week Staff Published
-
Uganda’s Ebola outbreak causes international alarm
Speed Read Infected patients reportedly escaping hospitals as cases rise
By Chas Newkey-Burden Published
-
Will new ‘bivalent booster’ head off a winter Covid wave?
Today's Big Question The jab combines the original form of the Covid vaccine with a version tailored for Omicron
By The Week Staff Published